A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.
Link To:
Sampson HA, Leung DY, Burks AW, Lack G, Bahna SL, Jones SM, Wong DA.
A phase II, randomized, double-blind, parallel-group, placebo-controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immunol. 2011 May;127(5):1309-1310.e1. http://www.ncbi.nlm.nih.gov/pubmed/21397314
http://www.jacionline.org/article/S0091-6749(11)00181-3/fulltext